Most people have received an email promising male sexual enhancement pills, recently the FDA and the EU have led concerted efforts to battle online drug fraud. Now industry is making steps in this direction, read about this new and interesting development. Full Article »

Japanese pharmaceutical giant Eisai has launched a groundbreaking new epilepsy drug in Europe following approval by the European Commission. Full Video »

Diabetes is a global threat. Researchers estimate that 26.6 million people in the Middle East and North Africa currently have diabetes. Six countries in the region are among the top 10 globally with the highest prevalence of diabetes. In this interview diabetes expert Professor Peter Schwarz, talks about the alarming growth of diabetes in the MENA region and strategies for prevention and management. Full Podcast »

To look forward we need to first look back. From 2008-2012 we saw big pharma collide creating larger companies. Genentech-Roche, Novartis-Alcon, Pfizer-Wyeth and GlaxoSmithKline-Human Genome Sciences just to name a few. During this same time frame the economies of the world have seen crashes and upheavals causing some of these same companies to “trim” their workforces. What does all this mean for 2013? Full Column »

International pharmaceutical companies expect a significant rise in business activity in emerging markets over the next five years with one in every two top pharma company managers expects shares of revenues coming from emerging markets to exceed by 30% by 2018. This study examines how there needs to be a change in the thinking within the boardrooms and an increase in in bespoke strategies being deployed individual to the markets they are serving – there cannot be a general emerging markets strategy – it must be more focused. Full Whitepaper »